Press
Media Enquiries
Here you will find our latest press releases, and approved media assets available for editorial use. For press inquiries, interview requests with Jane Oberholzer or Richard Wakefield, please contact us using the email addresses provided below.
Regarding Patients: Jane@curegbm.co.uk
Regarding Investment & C-Suite topics: Richard@curegbm.co.uk
Usable Quotes
“Glioblastoma is one of the hardest diagnoses in medicine to deliver. The standard of care has barely moved in twenty years, and patients and their families know it.
What draws me to this approach is that it is non-invasive and, in principle, repeatable, which matters for a disease that so often returns. Whether it can help patients is exactly the question a properly designed trial exists to answer.” – Prof. Philippe Schucht, Head of Neuro-oncology, Inselspital, Bern.
“We started CureGBM because we watched our father run out of options. It’s unacceptable that families face the same options today that they did two decades ago. Our aim is simple: to give a genuinely new approach a proper, rigorous test. We do not yet have the answers, and that is exactly why this research needs to happen.” – Richard Wakefield, Founder CureGBM.
Press Releases
‘New European effort aims to fund fresh research into glioblastoma, the brain cancer that has defied progress for twenty years’
‘British backed trial takes on glioblastoma, the brain cancer that has defied progress for twenty years’
Images for use
All images and brand assets in this media centre are cleared for editorial, journalistic, and broadcast use.
Credit must be attributed to CureGBM unless otherwise specified